Cytochrome P-450 CYP2C9 [cytochrom P450 CYP2C9]
topical
14
- Terms
-
CYP2C9
CYPIIC9
-
CYP2C9
CYPIIC9
Cytochrome P450 MP-4
Cytochrome P450 MP-8
Cytochrome P450 PB-1
Persistent link
https://www.medvik.cz/link/D065729
Definition
A cytochrome P-450 subtype that has specificity for acidic XENOBIOTICS. It oxidizes a broad range of important clinical drugs that fall under the categories of NONSTEROIDAL ANTI-INFLAMMATORY AGENTS; HYPOGLYCEMIC AGENTS; ANTCOAGULANTS; and DIURETICS.
- DUI
- D065729 MeSH Browser
- CUI
- M0590597
- Previous indexing
- *Aryl Hydrocarbon Hydroxylases (2003-2014)
- History note
- 2015
- Public note
- 2015
Combination
- antagonists & inhibitors
- Cytochrome P-450 CYP2C9 Inhibitors
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AN
- analysis 1
- BI
- biosynthesis 1
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- DF
- deficiency 0
- DE
- drug effects 2
- EC
- economics 0
- GE
- genetics 6
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 7
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PH
- physiology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UL
- ultrastructure 0
- UR
- urine 0
...
Occurrences in Medvik records
D
Chemicals and Drugs